Avita Medical company info

What does Avita Medical do?
Avita Medical (ASX:AVH) is a medical technology company that develops and commercialises regenerative medicine products for the treatment of chronic wounds. The company's flagship product is ReCell®, an autologous skin cell therapy that uses a patient's own skin cells to create a spray-on skin that is used to treat a variety of chronic wounds, including burns, diabetic ulcers, and pressure sores. Avita Medical is currently working on a number of projects, including the development of new ReCell® indications, the expansion of its global sales and marketing reach, and the development of new regenerative medicine products. Avita Medical's objectives are to become the leading provider of regenerative medicine products for the treatment of chronic wounds and to improve the lives of patients with chronic wounds.
Avita Medical company media
Company Snapshot

Is Avita Medical a public or private company?

key
Ownership
Public

How many people does Avita Medical employ?

people
Employees
200

What sector is Avita Medical in?

pie chart
Sector
Health Care

Where is the head office for Avita Medical?

location pin
Head Office
California, United States

What year was Avita Medical founded?

founded flag
Year Founded
1999
What does Avita Medical specialise in?
/Biotech /Health /Medical /Healthcare /Medicine

What are the products and/or services of Avita Medical?

Overview of Avita Medical offerings
ReCell® autologous skin cell therapy: ReCell® is a spray-on skin therapy that uses a patient's own skin cells to treat a variety of chronic wounds, including burns, diabetic ulcers, and pressure sores.
ReCell® for burns: ReCell® is approved by the FDA for the treatment of acute thermal burns in adult patients.
ReCell® for chronic wounds: ReCell® is approved by the FDA for the treatment of full-thickness skin defects, including diabetic ulcers and pressure sores.
ReCell® for vitiligo: ReCell® is being investigated for the treatment of vitiligo, a chronic skin condition that causes depigmentation of the skin.
Rejuvenation: Avita Medical is exploring novel RNA-based approaches for rejuvenation.
Research and development: Avita Medical is committed to research and development, with a focus on developing new and innovative regenerative medicine products.

Who is in the executive team of Avita Medical?

Avita Medical leadership team
  • Mr. James M. Corbett
    Mr. James M. Corbett
    CEO, President & Executive Director
  • Mr. David  O'Toole
    Mr. David O'Toole
    Chief Financial Officer
  • Ms. Donna  Shiroma
    Ms. Donna Shiroma
    General Counsel, Chief Compliance Officer & Secretary
  • Mr. David  Fencil
    Mr. David Fencil
    Senior Vice President of Global Operations
  • Dr. Katie  Bush Ph.D.
    Dr. Katie Bush Ph.D.
    Senior Vice President of Scientific & Medical Affairs
  • Ms. Jessica  Ekeberg
    Ms. Jessica Ekeberg
    Investor Relations Executive
  • Ms. Debbie  Garner
    Ms. Debbie Garner
    Senior Vice President of Global Marketing & Strategy
  • Mr. Rob  Hall
    Mr. Rob Hall
    Senior Vice President of Human Resources